4 results match your criteria: "Arizona Health Sciences Centre[Affiliation]"

Biobanking and Regenerative Medicine: An Overview.

J Clin Med

May 2018

Department of Immunobiology, Arizona Health Sciences Centre, University of Arizona, Room 6122, P.O. Box 245221, Tucson, AZ 85721, USA.

View Article and Find Full Text PDF

Bilateral symmetry of biomechanical properties in mouse femora.

Med Eng Phys

May 2004

Orthopaedic Research Lab, Department of Orthopaedic Surgery, Arizona Health Sciences Centre, University of Arizona, Room 8352, P.O. Box 245194, Tucson, AZ 85724-5064, USA.

Bone healing and remodeling are commonly examined in animal models by comparing one femur (experimental) to the contralateral femur (control) with the assumption that they are identical with respect to their biomechanical properties. While past studies have characterized the symmetry in geometrical properties in many types of animal bones, few studies have compared the symmetry in the biomechanical properties. The purpose of this study was to determine whether there is symmetry in the mechanical properties of mouse femora.

View Article and Find Full Text PDF

Health dilemmas at the borders--a global challenge.

World Health Forum

September 1997

University of Arizona Health Sciences Centre, WHO Collaborating Centre Border and Rural Health Research and Development, Tempe 85283, USA.

The health and safety of border crossers and people who live in border areas are widely neglected. The remoteness of many communities living near international borders makes it difficult to provide them with services, and if a country's border controls are inadequate there is an increased risk from communicable diseases for its entire population. Substance abuse and associated behavioural problems can be more common in border regions for the same reason.

View Article and Find Full Text PDF

Seven hundred twenty congenitally dislocated or subluxated hips in 550 patients less than one year old, treated with the Pavlik harness, were retrospectively reviewed. Overall, 11% of the hips proved irreducible by Pavlik harness treatment, 9% had dysplasia at the end of harness treatment, and 5% developed dysplasia by the age of two years two months (average). Fourteen percent of the hips positive for Ortolani's sign, 6% of the hips positive for Barlow's sign, and 2% of the congenitally subluxated hips required open or closed reduction followed by plaster hip spica immobilization.

View Article and Find Full Text PDF